Description
Nobesit XR 1 gm is an extended-release formulation of metformin hydrochloride, developed by Incepta Pharmaceuticals Ltd., designed to manage type 2 diabetes mellitus, particularly in overweight patients when diet and exercise alone do not provide adequate glycemic control. Metformin, the active ingredient, works by decreasing hepatic glucose production, reducing intestinal glucose absorption, and enhancing insulin sensitivity, thereby lowering both basal and postprandial plasma glucose levels without causing hypoglycemia. The extended-release mechanism allows for once-daily dosing, improving patient adherence and minimizing gastrointestinal side effects commonly associated with immediate-release metformin. Nobesit XR 1 gm is typically taken with food to reduce the risk of gastrointestinal discomfort. It's important to note that the maximum recommended daily dose for adults is 2000 mg, and doses above this may be better tolerated when divided into multiple administrations. Patients should follow their healthcare provider's instructions regarding dosage and administration, and regular monitoring of renal function is advised, as metformin is contraindicated in patients with severe renal impairment.
.jpg)
.jpeg)
.jpg)
.png)
.jpeg)
.jpeg)
 400MG.jpg)
.jpg)
.jpg)
.jpg)
.jpeg)
.jpg)
 100 IU 3 ML.webp)
.jpg)
.webp)
.jpg)
.webp)
.webp)
Change Language